��ҹѰ��

Professor Ijeoma Uchegbu, a Professor of Pharmaceutical Nanoscience known for her ground-breaking work in nanoparticle drug delivery, will become the 7th President of ��ҹѰ��. She will succeed current President, Professor Jane Clarke, on 1 October 2024.

Professor Uchegbu is currently Professor of Pharmaceutical Nanoscience at University College London. Her pioneering work on the mechanisms of drug transport have led to the development of new treatments which promise to transform pain relief, including the enkephalin pain medicine candidate (EnveltaÔ), designed to address the opioid crisis.

Her work has won her numerous awards, fellowships and accolades, and she holds positions on several academic boards and councils including the Wellcome Trust, the Academy of Medical Sciences and is an honorary Fellow of the Royal Society of Chemistry. She has also played a leading role during her time at UCL as Pro Vice Provost for Africa and the Middle East, in forging new research partnerships in those regions and as UCL’s Provost’s Envoy for Race Equality, steering the organisation’s race equality agenda.

Professor Uchegbu responded to her election by stating, “I am so thrilled to be joining ��ҹѰ��, an ambitious and forward-thinking College. It will be an honour to lead such a lively, diverse and engaged student community in an environment where people are stimulated culturally, socially and intellectually. I look forward to working with the Governing Body, staff and students to help realise their ambitions and potential.”

The current President, Professor Jane Clarke commented: “I congratulate Ijeoma for being elected President of ��ҹѰ��.  If she finds being the leader of the ‘Wolfpack’ half as rewarding as I have then I can assure her that she will enjoy herself immensely.” 

Professor Uchegbu will take up her post at the start of the 2024-2025 academic year, on 1st October 2024.

 

Photograph by Antonio Olmos.